LINC00641 and lung cancer: Furthermore, compared to the control group, knockdown of LINC00641 increased the cellular ROS levels and the intracellular concentrations of both ferrous iron (Fe2+) and total iron (Fe) under the treatment of RSL3 (Fig. 6F–H), suggesting that LINC00641 downregulation could increase ferroptotic sensitivity in lung cancer cells.